Opportunity ID: 123673

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: PAR-11-342
Funding Opportunity Title:: Neurological Emergencies Treatment Trials (NETT) Network Clinical Site Hubs for year 2011 (U10)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Sep 20, 2011
Last Updated Date::
Original Closing Date for Applications:: Dec 09, 2011
Current Closing Date for Applications:: Dec 09, 2011
Archive Date:: Jan 09, 2012
Estimated Total Program Funding::
Award Ceiling:: $200,000
Award Floor:: $

Eligibility

Eligible Applicants:: For profit organizations other than small businesses
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name:: National Institutes of Health
Description:: The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite new and renewal applications to participate as Clinical Site Hubs in the Neurological Emergencies Treatment Trials (NETT) Network.The goal of this existing network is to develop and widely implement efficacious treatments for patients with a broad spectrum of neurological emergencies in order to decrease the morbidity and mortality associated with neurological disease.Their objective is to conduct multiple, large, streamlined phase III clinical trials involving neurological emergencies.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Package No: 1

Related Documents